Dabigatran discontinuation in "real-world" practice among Chinese population

被引：0
|
作者：
Ho, M. H. [1 ]
Cheung, E. [1 ]
Ho, C. W. [1 ]
Tse, H. F. [1 ]
Siu, C. W. [1 ]
机构：
[1] Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P6232
引用
收藏
页码：1104 / 1104
页数：1
相关论文
共 50 条
  • [21] Discontinuation of tyrosine kinase inhibitors in CML patients in real-world clinical practice at a single institution
    Nuno Cerveira
    Bruno Loureiro
    Susana Bizarro
    Cecília Correia
    Lurdes Torres
    Susana Lisboa
    Joana Vieira
    Rui Santos
    Dulcineia Pereira
    Cláudia Moreira
    Sérgio Chacim
    Nélson Domingues
    Ana Espírito-Santo
    Isabel Oliveira
    Ilídia Moreira
    Luísa Viterbo
    Ângelo Martins
    Manuel R. Teixeira
    José M. Mariz
    BMC Cancer, 18
  • [22] Discontinuation of tyrosine kinase inhibitors in CML patients in real-world clinical practice at a single institution
    Cerveira, Nuno
    Loureiro, Bruno
    Bizarro, Susana
    Correia, Cecilia
    Torres, Lurdes
    Lisboa, Susana
    Vieira, Joana
    Santos, Rui
    Pereira, Dulcineia
    Moreira, Claudia
    Chacim, Sergio
    Domingues, Nelson
    Espirito-Santo, Ana
    Oliveira, Isabel
    Moreira, Ilidia
    Viterbo, Luisa
    Martins, Angelo
    Teixeira, Manuel R.
    Mariz, Jose M.
    BMC CANCER, 2018, 18
  • [23] Real-world variability in dabigatran levels in patients with atrial fibrillation
    Chan, N. C.
    Coppens, M.
    Hirsh, J.
    Ginsberg, J. S.
    Weitz, J. I.
    Vanassche, T.
    Douketis, J. D.
    Schulman, S.
    Eikelboom, J. W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (03) : 353 - 359
  • [24] A Methodological Appraisal of Recent Real-World Data Publications on Dabigatran
    Zint, Kristina
    Kreuzer, Joerg
    JAMA INTERNAL MEDICINE, 2015, 175 (07) : 1244 - 1244
  • [25] Dabigatran in 'real-world' clinical practice for stroke prevention in patients with non-valvular atrial fibrillation
    Potpara, Tatjana S.
    THROMBOSIS AND HAEMOSTASIS, 2015, 114 (06) : 1093 - 1098
  • [26] Adherence to anticoagulant treatment with dabigatran and rivaroxaban in a real-world setting
    Khalili, F. A.
    Suryanarayan, D.
    Lindstrom, C.
    Schulman, S.
    Majeed, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 117 - 117
  • [27] 'Real-world' haemorrhagic rates for warfarin and dabigatran using population-level data in New Zealand
    Nishtala, Prasad S.
    Gnjidic, Danijela
    Jamieson, Hamish A.
    Hanger, H. Carl
    Kaluarachchi, Chanaka
    Hilmer, Sarah N.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 203 : 746 - 752
  • [28] Adherence of Dabigatran and the Influence of Dabigatran-induced Gastrointestinal Discomfort in the Real World Practice
    Han, Seongwook
    Hwang, Jongmin
    Lee, So Ryoung
    Choi, Eue-Keun
    Park, Hyoung-Seob
    Lee, Young Soo
    Ahn, Jin Hee
    Choi, Jong-il
    Shin, Dong Gu
    Kim, Dae-Kyeong
    Park, Jong Sung
    Hwang, Ki Won
    Cha, Tae-Joon
    CIRCULATION, 2019, 140
  • [29] Dabigatran versus Warfarin Among Patients with Atrial Fibrillation: Real-World Post-Market Results
    Thelus, Rosenie
    Villines, Todd C.
    Coster, Trinka S.
    CIRCULATION, 2012, 126 (21)
  • [30] Real-world investigation of the efficacy and safety of secukinumab for psoriasis treatment in a Chinese population
    Zeng, Jing-Xin
    Luo, Quan
    Wen, Ju
    Tian, Xin
    Zhou, Xin
    Li, Wei
    Tang, Ya-Ping
    Zhang, San-Quan
    Liu, Wei-Yu
    Zhu, Hui-Lan
    Zhang, Xi-Bao
    CHINESE MEDICAL JOURNAL, 2021, 134 (01) : 117 - 119
12345